Pacira BioSciences (PCRX) Retained Earnings (2010 - 2026)
Pacira BioSciences (PCRX) recorded quarterly Retained Earnings of -$196.4 million in Q1 2026, up 1.46% quarter-over-quarter from -$199.3 million in Q4 2025, and up 2.55% on a YoY basis from -$191.5 million in Q1 2025.
Pacira BioSciences (PCRX) Retained Earnings (2010 - 2026) Analysis & Trends
Pacira BioSciences' Retained Earnings history runs 17 years deep, the most recent figure standing at -$196.4 million for Q1 2026.
- In Q1 2026, Retained Earnings rose 2.55% year-over-year to -$196.4 million; the TTM figure through Mar 2026 stood at -$196.4 million (up 2.55% YoY), while the FY2025 annual figure was -$199.3 million, up 3.41% from the prior year.
- Retained Earnings was -$196.4 million for Q1 2026 at Pacira BioSciences, up from -$199.3 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $4.1 million in Q3 2025 to a low of -$206.4 million in Q2 2025.
- Historically, Retained Earnings has averaged -$96.5 million across 5 years, with a median of -$106.8 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings soared 6880.0% in 2024, then plunged 196662.86% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$148.8 million in 2022, then increased by 28.2% to -$106.8 million in 2023, then plunged by 93.22% to -$206.4 million in 2024, then gained by 3.41% to -$199.3 million in 2025, then climbed by 1.46% to -$196.4 million in 2026.
- The last three Retained Earnings figures came in at -$196.4 million (Q1 2026), -$199.3 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | Pacira BioSciences | 940.31 Mn | 738.13 Mn | 140.96 Mn | -196.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -196.41 Mn |
| Dec 31, 2025 | -199.32 Mn |
| Sep 30, 2025 | 4.12 Mn |
| Jun 30, 2025 | -206.39 Mn |
| Mar 31, 2025 | -201.54 Mn |
| Dec 31, 2024 | -206.36 Mn |
| Sep 30, 2024 | 678,000.00 |
| Jun 30, 2024 | 105,000.00 |
| Mar 31, 2024 | -97.82 Mn |
| Dec 31, 2023 | -106.80 Mn |
| Sep 30, 2023 | -10,000.00 |
| Jun 30, 2023 | -142.52 Mn |
| Mar 31, 2023 | -137,000.00 |
| Dec 31, 2022 | -148.75 Mn |
| Sep 30, 2022 | -670,000.00 |
| Jun 30, 2022 | -137.96 Mn |
| Mar 31, 2022 | -527,000.00 |
| Dec 31, 2021 | 167,000.00 |
| Sep 30, 2021 | 153,000.00 |
| Jun 30, 2021 | 181,000.00 |